Show simple item record

Multiple TLR Activating Nanocomplexes for Cancer Immunotherapy

Advantages, Limitations and Design Considerations

dc.contributor.advisorLamprecht, Alf
dc.contributor.authorÜnal, Ayşe
dc.date.accessioned2026-06-16T05:05:04Z
dc.date.issued16.06.2026
dc.identifier.urihttps://hdl.handle.net/20.500.11811/14208
dc.description.abstract(noch nicht zugänglich / not yet accessible)en
dc.language.isoeng
dc.rightsIn Copyright
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectKrebsimmuntherapie
dc.subjectToll-like-Rezeptoren
dc.subjectMulti-TLR-aktivierende Nanokomplexe
dc.subjectTLR4
dc.subjectTLR7/8
dc.subjectTLR9
dc.subjectTLR-Toleranz
dc.subjectCancer immunotherapy
dc.subjectToll-like receptors
dc.subjectMulti TLR activating nanocomplexes
dc.subjectTLR tolerance
dc.subject.ddc615 Pharmakologie, Therapeutik
dc.titleMultiple TLR Activating Nanocomplexes for Cancer Immunotherapy
dc.title.alternativeAdvantages, Limitations and Design Considerations
dc.typeDissertation oder Habilitation
dc.identifier.doihttps://doi.org/10.48565/bonndoc-884
dc.publisher.nameUniversitäts- und Landesbibliothek Bonn
dc.publisher.locationBonn
dc.rights.accessRightsembargoedAccess
dc.date.embargoEndDate01.07.2027
dc.identifier.urnhttps://nbn-resolving.org/urn:nbn:de:hbz:5-90464
ulbbn.pubtypeErstveröffentlichung
ulbbnediss.affiliation.nameRheinische Friedrich-Wilhelms-Universität Bonn
ulbbnediss.affiliation.locationBonn
ulbbnediss.thesis.levelDissertation
ulbbnediss.dissID9046
ulbbnediss.date.accepted20.05.2026
ulbbnediss.instituteMathematisch-Naturwissenschaftliche Fakultät : Fachgruppe Pharmazie / Pharmazeutisches Institut
ulbbnediss.fakultaetMathematisch-Naturwissenschaftliche Fakultät
dc.contributor.coRefereeArıca Yegin, Betül
ulbbnediss.contributor.orcidhttps://orcid.org/0000-0002-2673-7321


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

The following license files are associated with this item:

InCopyright